Molecular evidence for the clonal origin of blast crisis in chronic myeloid leukaemia.

por Zalcberg, J. R., Friedlander, M. L., Minden, M. D.
Publicado 1986

Breast cancer in young women and its impact on reproductive function

por Hickey, M., Peate, M., Saunders, C.M., Friedlander, M.
Publicado 2009

Cellular DNA content--a stable feature in epithelial ovarian cancer.

por Friedlander, M. L., Taylor, I. W., Russell, P., Tattersall, M. H.
Publicado 1984

Ovarian tumour xenografts in the study of the biology of human epithelial ovarian cancer.

por Friedlander, M. L., Russell, P., Taylor, I. W., Tattersall, M. H.
Publicado 1985

Australian experience of a modified schedule of FOLFOX with high activity and tolerability and improved convenience in untreated metastatic colorectal cancer patients

por Goldstein, D, Mitchell, P, Michael, M, Beale, P, Friedlander, M, Zalcberg, J, White, S, Clarke, S
Publicado 2005

Demonstration of somatic rearrangements and genomic heterogeneity in human ovarian cancer by DNA fingerprinting.

por Boltz, E. M., Harnett, P., Leary, J., Houghton, R., Kefford, R. F., Friedlander, M. L.
Publicado 1990

Allelic losses in carcinoma in situ and testicular germ cell tumours of adolescents and adults: evidence suggestive of the linear progression model

por Faulkner, S W, Leigh, D A, Oosterhuis, J W, Roelofs, H, Looijenga, L H J, Friedlander, M L
Publicado 2000

Making hard choices easier: a prospective, multicentre study to assess the efficacy of a fertility-related decision aid in young women with early-stage breast cancer

por Peate, M, Meiser, B, Cheah, B C, Saunders, C, Butow, P, Thewes, B, Hart, R, Phillips, K-A, Hickey, M, Friedlander, M
Publicado 2012

Genetic associations of fatigue and other symptoms following breast cancer treatment: A prospective study

por Cameron, B., Webber, K., Li, H., Bennett, B.K., Boyle, F., de Souza, P., Wilcken, N., Lynch, J., Friedlander, M., Goldstein, D., Lloyd, A.R.
Publicado 2020

A comparative analysis exposes an amplification delay distinctive to SARS-CoV-2 Omicron variants of clinical and public health relevance

por Brown, K.L., Ceci, A., Roby, C., Briggs, R., Ziolo, D., Korba, R., Mejia, R., Kelly, S.T., Toney, D., Friedlander, M.J., Finkielstein, C.V.
Publicado 2022

Adequacy of risk-reducing gynaecologic surgery in BRCA1 or BRCA2 mutation carriers and other women at high risk of pelvic serous cancer

por Kiely, B. E., Friedlander, M. L., Milne, R. L., Stanhope, L., Russell, P., Jenkins, M. A., Weideman, P., McLachlan, S. A., Grant, P., Hopper, J. L., Phillips, K. A.
Publicado 2011

Dose and time effects of solar‐simulated ultraviolet radiation on the in vivo human skin transcriptome

por Bustamante, M., Hernandez‐Ferrer, C., Tewari, A., Sarria, Y., Harrison, G.I., Puigdecanet, E., Nonell, L., Kang, W., Friedländer, M.R., Estivill, X., González, J.R., Nieuwenhuijsen, M., Young, A.R.
Publicado 2019

Improved quality of risk-reducing salpingo-oophorectomy in Australasian women at high risk of pelvic serous cancer

por Lee, Y. C., Bressel, M., Grant, P., Russell, P., Smith, C., Picken, S., Camm, S., Kiely, B. E., Milne, R. L., McLachlan, S. A., Hickey, M., Friedlander, M. L., Hopper, J. L., Phillips, K. A.
Publicado 2017

Carboplatin–paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer

por Lee, C K, Gurney, H, Brown, C, Sorio, R, Donadello, N, Tulunay, G, Meier, W, Bacon, M, Maenpaa, J, Petru, E, Reed, N, Gebski, V, Pujade-Lauraine, E, Lord, S, Simes, R J, Friedlander, M
Publicado 2011

Association of tamoxifen use and reduced risk of contralateral breast cancer for BRCA1 and BRCA2 mutation carriers

por Phillips, KA, Milne, RL, Rookus, MA, Goldgar, D, Friedlander, M, McLachlan, SA, Buys, S, Antoniou, AC, Birch, K, Terry, MB, Easton, DF, Weideman, P, Daly, M, Andrieu, N, John, EM, Hooning, MJ, Andrulis, IL, Caldes, T, Olsson, H, Hopper, JL
Publicado 2012

Development and implementation of a scalable and versatile test for COVID-19 diagnostics in rural communities

por Ceci, A., Muñoz-Ballester, C., Tegge, A. N., Brown, K. L., Umans, R. A., Michel, F. M., Patel, D., Tewari, B., Martin, J., Alcoreza, O., Maynard, T., Martinez-Martinez, D., Bordwine, P., Bissell, N., Friedlander, M. J., Sontheimer, H., Finkielstein, C. V.
Publicado 2021

Prognostic nomogram to predict progression-free survival in patients with platinum-sensitive recurrent ovarian cancer

por Lee, C K, Simes, R J, Brown, C, Lord, S, Wagner, U, Plante, M, Vergote, I, Pisano, C, Parma, G, Burges, A, Bourgeois, H, Högberg, T, Bentley, J, Angleitner-Boubenizek, L, Ferrero, A, Richter, B, Hirte, H, Gebski, V, Pfisterer, J, Pujade-Lauraine, E, Friedlander, M
Publicado 2011

Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial

por Ledermann, J.A., Embleton-Thirsk, A.C., Perren, T.J., Jayson, G.C., Rustin, G.J.S., Kaye, S.B., Hirte, H., Oza, A., Vaughan, M., Friedlander, M., González-Martín, A., Deane, E., Popoola, B., Farrelly, L., Swart, A.M., Kaplan, R.S., Parmar, M.K.B.
Publicado 2021

Somatic mutations of KIT in familial testicular germ cell tumours

por Rapley, E A, Hockley, S, Warren, W, Johnson, L, Huddart, R, Crockford, G, Forman, D, Leahy, M G, Oliver, D T, Tucker, K, Friedlander, M, Phillips, K-A, Hogg, D, Jewett, M A S, Lohynska, R, Daugaard, G, Richard, S, Heidenreich, A, Geczi, L, Bodrogi, I, Olah, E, Ormiston, W J, Daly, P A, Looijenga, L H J, Guilford, P, Aass, N, Fosså, S D, Heimdal, K, Tjulandin, S A, Liubchenko, L, Stoll, H, Weber, W, Einhorn, L, Weber, B L, McMaster, M, Greene, M H, Bishop, D T, Easton, D, Stratton, M R
Publicado 2004